» Articles » PMID: 23442957

Cysteine Scanning of CFTR's First Transmembrane Segment Reveals Its Plausible Roles in Gating and Permeation

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2013 Feb 28
PMID 23442957
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Previous cysteine scanning studies of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel have identified several transmembrane segments (TMs), including TM1, 3, 6, 9, and 12, as structural components of the pore. Some of these TMs such as TM6 and 12 may also be involved in gating conformational changes. However, recent results on TM1 seem puzzling in that the observed reactive pattern was quite different from those seen with TM6 and 12. In addition, whether TM1 also plays a role in gating motions remains largely unknown. Here, we investigated CFTR's TM1 by applying methanethiosulfonate (MTS) reagents from both cytoplasmic and extracellular sides of the membrane. Our experiments identified four positive positions, E92, K95, Q98, and L102, when the negatively charged MTSES was applied from the cytoplasmic side. Intriguingly, these four residues reside in the extracellular half of TM1 in previously defined CFTR topology; we thus extended our scanning to residues located extracellularly to L102. We found that cysteines introduced into positions 106, 107, and 109 indeed react with extracellularly applied MTS probes, but not to intracellularly applied reagents. Interestingly, whole-cell A107C-CFTR currents were very sensitive to changes of bath pH as if the introduced cysteine assumes an altered pKa-like T338C in TM6. These findings lead us to propose a revised topology for CFTR's TM1 that spans at least from E92 to Y109. Additionally, side-dependent modifications of these positions indicate a narrow region (L102-I106) that prevents MTS reagents from penetrating the pore, a picture similar to what has been reported for TM6. Moreover, modifications of K95C, Q98C, and L102C exhibit strong state dependency with negligible modification when the channel is closed, suggesting a significant rearrangement of TM1 during CFTR's gating cycle. The structural implications of these findings are discussed in light of the crystal structures of ABC transporters and homology models of CFTR.

Citing Articles

The structures of protein kinase A in complex with CFTR: Mechanisms of phosphorylation and noncatalytic activation.

Fiedorczuk K, Iordanov I, Mihalyi C, Szollosi A, Csanady L, Chen J Proc Natl Acad Sci U S A. 2024; 121(46):e2409049121.

PMID: 39495916 PMC: 11573500. DOI: 10.1073/pnas.2409049121.


Structural identification of a selectivity filter in CFTR.

Levring J, Chen J Proc Natl Acad Sci U S A. 2024; 121(9):e2316673121.

PMID: 38381791 PMC: 10907310. DOI: 10.1073/pnas.2316673121.


Role of Hydrophobic Amino-Acid Side-Chains in the Narrow Selectivity Filter of the CFTR Chloride Channel Pore in Conductance and Selectivity.

Linsdell P J Membr Biol. 2023; 256(4-6):433-442.

PMID: 37823914 DOI: 10.1007/s00232-023-00294-w.


CFTR Modulators: From Mechanism to Targeted Therapeutics.

Yeh H, Sutcliffe K, Sheppard D, Hwang T Handb Exp Pharmacol. 2022; 283:219-247.

PMID: 35972584 DOI: 10.1007/164_2022_597.


Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.

Farinha C, Callebaut I Biosci Rep. 2022; 42(7).

PMID: 35707985 PMC: 9251585. DOI: 10.1042/BSR20212006.


References
1.
Serohijos A, Hegedus T, Aleksandrov A, He L, Cui L, Dokholyan N . Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A. 2008; 105(9):3256-61. PMC: 2265173. DOI: 10.1073/pnas.0800254105. View

2.
Pascual J, Wang D, Yang R, Shi L, Yang H, De Vivo D . Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants. J Biol Chem. 2008; 283(24):16732-42. PMC: 2423257. DOI: 10.1074/jbc.M801403200. View

3.
Dawson R, Locher K . Structure of a bacterial multidrug ABC transporter. Nature. 2006; 443(7108):180-5. DOI: 10.1038/nature05155. View

4.
LINDLEY H . A study of the kinetics of the reaction between thiol compounds and choloracetamide. Biochem J. 1960; 74:577-84. PMC: 1204257. DOI: 10.1042/bj0740577. View

5.
Kopeikin Z, Sohma Y, Li M, Hwang T . On the mechanism of CFTR inhibition by a thiazolidinone derivative. J Gen Physiol. 2010; 136(6):659-71. PMC: 2995156. DOI: 10.1085/jgp.201010518. View